Global Hepatitis B Vaccines Market to Reach US$3.9 Billion by 2030 The global market for Hepatitis B Vaccines estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.9 Billion by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Adult Application, one of the segment ...

The molecular diagnostics market is valued at an estimated USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030 at a CAGR of 9.6% during the forecast period. Molecular diagnostics plays a vital role in modern healthcare by enabling disease detection at the molecular and gene ...

Hepatitis Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on hepatitis therapeutics market which is experiencing strong growth. The report ...

Hepatitis Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on hepatitis drugs market which is experiencing strong growth. The report gives a guide ...

Hepatitis B Virus (HBV) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on hepatitis b virus (hbv) market which is experiencing strong growth. The repo ...

The infectious disease diagnostics market is projected to reach USD 42.20 billion by 2030 from USD 26.58 billion in 2025, at a CAGR of 9.7% during the forecast period. The factors driving the market growth include the increasing emphasis on decentralized diagnostics and the rising demand for CLIA-wa ...

The global point-of-care molecular diagnostics market is projected to reach USD 7.09 billion by 2030, from USD 4.30 billion in 2025, with a CAGR of 10.5%. The market is primarily driven by the increasing focus on decentralized testing, which facilitates faster clinical decisions across various care ...

The vaccines market is expected to reach 63.66 billion USD in 2030, up from 50.46 billion USD in 2025, growing at a CAGR of 4.8% during the forecast period. Factors such as the high incidence of contagious diseases, innovation in vaccine technology, government support and substantial funding for vac ...

Global Alcoholic Hepatitis Market: Industry Overview The global alcoholic hepatitis market is primarily driven by the increasing prevalence of global alcohol consumption, rising alcohol-related liver diseases, and increased public awareness of liver health. Alcoholic hepatitis, a severe form of alco ...

Global Hepatitis D Market, Analysis and Forecast: 2025-2035 Hepatitis D is a rare, serious, liver disease caused by the hepatitis D virus (HDV), which can only infect individuals who are already infected with the hepatitis B virus (HBV). The virus causes significant liver damage, leading to symptoms ...

According to our (Global Info Research) latest study, the global Hepatitis B Vaccines market size was valued at US$ 1404 million in 2024 and is forecast to a readjusted size of USD 2143 million by 2031 with a CAGR of 6.3% during review period. Hepatitis B vaccine is a vaccine that prevents hepatitis ...

Report Scope This report offers an analysis of the global market for infectious disease therapeutics, vaccines, and diagnostics. The infectious diseases covered in the report include human immunodeficiency virus (HIV) infection, seasonal influenza (including influenza A and B), hepatitis B, hepatiti ...

Global Hepatitis B Treatment Market to Reach US$5.4 Billion by 2030 The global market for Hepatitis B Treatment estimated at US$4.7 Billion in the year 2024, is expected to reach US$5.4 Billion by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Acute Type, one of the segments ana ...

Global Hepatitis B and C Diagnostics Market to Reach US$9.6 Billion by 2030 The global market for Hepatitis B and C Diagnostics estimated at US$6.8 Billion in the year 2024, is expected to reach US$9.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Immunodiagnostics, ...

Global antiviral drugs market is estimated to be valued at USD 67.04 Bn in 2025 and is expected to exhibit a CAGR of 5.3% during the forecast period (2025-2032). The global antiviral drugs market has been witnessing steady growth over the past few years. Antiviral drugs, also known as antiviral agen ...

This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent s ...

This study covers the world outlook for viral infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is o ...

This study covers the world outlook for mono hepatitis B vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for hepatitis b therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of th ...

This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of ...

This study covers the world outlook for hepatitis test solution-diagnosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for hepatitis c therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the ...

This study covers the world outlook for anti-hepatitis drugs and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count ...

This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is ...